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Abstract 
Background: To compare the clinical efficacy of 
Azithromycin versus Ofloxacin in the treatment of 
typhoid fever in terms of the proportion of children 
becoming afebrile on 5th day of treatment. 
Methods: In this  randomized controlled trail 230 
patients of Typhoid fever, age ranging  from 2-12 
years, were included. One hundred and fifteen 
patients were given Azithromycin and 115 patients 
were given Ofloxacin randomly. Patients were  
randomly divided into two groups . Group A was 
given Azithromycin 10 mg/kg/day once daily orally 
for 7 days.Group B was given Ofloxacin 
15mg/kg/day in two divided doses orally for 7 days. 
Both the groups were observed for duration of 
becoming afebrile on 5th day of treatment. 
Investigation to be done during hospital stay was 
Typhidot (IgM antibodies) . Chi-square test was 
used to compare efficacy (afebrile on day 5) of both 
drugs.P-value < 0.05 was considered significant.          
Results: The age range was from 5 to 12 years with 
a mean age of 7.7 ±2.45. 125 (54.3 %) were males and 
105 (45.7 %) were females. 59.1% patients became 
afebrile on 5th day of treatment while 40.9 % patients 
failed to become afebrile.In the Azithromycin group 
69.6 % patients became afebrile on day 5th . In the 
Ofloxacin group, 48.7% became afebrile on day 5th . 
Proportion of patients becoming afebrile on 5th day 
of treatment was significantly higher in the 
azithromycin group as compared to Ofloxacin group 
(p= 0.01) 
Conclusion: Azithromycin is more effective in 
children with typhoid fever in terms of greater 
proportion of children becoming afebrile on day 5th 
of treatment 




       Typhoid fever is a major health problem .It is  an 
important cause of mortality and morbidity world 
wide but with high incidence in developing countries 
of Asia. It is endemic in Pakistan and India. A recent 
estimate of disease burden worldwide showed that in 
year 2000, about 22 million new cases of typhoid fever 
were reported with 210,000 deaths due to typhoid 
fever and 5.4 million cases of paratyphoid fever1. A 
study conducted in May 2004 showed that South East  
Asia and Central Asia are the regions in which 
incidence of  typhoid fever is high, 100/100,000 
cases/year. Rest of Asia, Africa, Caribbean, Latin 
America, part of Europe and North America are the 
regions with medium incidence of typhoid fever, 10-
100/100,000 cases/per year. The rest of the developed 
world have low incidence of typhoid fever, 
<10/100,000 cases/year2. Pakistan has a high incidence 
of typhoid fever. It is the 4th commonest cause of death 
. According to a report of WHO, the incidence of 
typhoid fever in Pakistan is 573.2 per 100,000 persons 
per year. 3,4  
    Risk factors for transmission of typhoid fever and 
paratyphoid fever include over crowding, poor hand 
washing and poor personal hygiene, eating street food, 
using water without boiling, sharing food, consuming 
iced drinks, lower socioeconomic group, and poor 
sanitory conditions in houses. Typhoid fever is 
frequently transmitted in summer and during rainy 
season due to contamination of water used for 
drinking5 
   The incubation period of typhoid fever is one to two 
weeks.6 After ingestion of contaminated food or water, 
the bacteria enters into the lamina properia of 
intestine, from where it is taken up by macrophages 
which then spread the organism via lymphatics to 
various organs of host causing disease manifestations.7  
The clinical picture of the disease may be mild or 
severe enough to cause fatal complications and death 
of the patient. Patients may present with high grade 
fever, anorexia, nausea, vomiting and diarrhea or 
sometimes abdominal pain, pallor, constipation, 
jaundice, myalgias, arthralgias and 
hepatosplenomegaly or encephalopathy, or ileus 
intestinal perforation. Factors that determine the 
severity of the disease include, the duration of illness 
before starting appropriate therapy, age of the patient, 
previous vaccination, immunity of the host, dose of 
inoculating organism and choice of antibiotic being 
used for treatment. 8 
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   Gold standard for diagnosis of typhoid fever is blood 
culture and bone marrow culture. Other tests which 
are commonly used include Typhidot test and PCR. 9 
Case fatality rate of typhoid fever is 10 % without 
proper treatment however it can be reduced to 1 % 
with proper treatment with antibiotics 10. About 15 % 
of infected patients with salmonella died in past in 
pre-antibiotic era. The survivors used to have 
prolonged disability and illness lasting for weeks or 
even for many months. Antibiotic therapy is necessary 
for treatment of typhoid fever.11 
    Multi Drug Resistance (MDR) is the term used to 
describe the resistance to all first line antimicrobials 
used for treatment of typhoid fever including 
ampicillin, Trimethoprim-Sulfamethoxazole and 
chloramphenicol. Due to these MDR strains, 
fluroquinolones are the drugs of choice 12. A study was 
conducted in India in 2001 that showed 100% 
susceptibility of all isolated Salmonella strains to 
Ciprofloxacin.13Increased use of fluoroquinolones 
again created problem in treatment of typhoid fever 
due to emergence of strains that were resistant to 
Fluoroquinolones.14,15  
    This resistance again forced the physicians to search 
for newer antibiotics to which salmonella is sensitive. 
Among newer fluoroquinolones, Gatifloxacin is a 
better alternative. 3rd generation Cephalosporins like 
Ceftriaxone are now commonly being used for the 
treatment of typhoid fever.16 Treatment of 
ciprofloxacin resistant typhoid fever now  narrows 
down to 3rd and 4th generation cephalosporins, 
Azithromycin, Penams and Tigecycline.17  
 
Patients and Methods: 
This  randomized controlled trail was conducted in 
Pediatric Department of Holy Family Hospital, 
Rawalpindi ,from March 2012 to September 
2012.Sample size was calculated by WHO calculator. 
Total 230 diagnosed patients of Typhoid fever, age 
range from 2-12 years, were included. Patients had 
fever >37°C in the presence of at least one or more of 
the signs and symptoms , i.e., persistent headache, 
abdominal pain or discomfort, splenomegaly / 
hepatomegaly, rose spots on skin and vomiting.One 
hundred and fifteen patients were given Azithromycin 
and 115 patients were given Ofloxacin randomly. 
Patients were  randomly divided into two groups, A 
and B . Group A was given Azithromycin 10 
mg/kg/day once daily orally for 7 days.Group B was 
given Ofloxacin 15mg/kg/day in two divided doses 
orally for 7 days. Both the groups were observed for 
duration of becoming afebrile on 5th day of treatment. 
Investigation to be done during hospital stay was 
Typhidot (IgM antibodies) . Chi-square test was used 
to compare efficacy (afebrile on day 5) of both drugs.P-
value < 0.05 was considered significant.             
 
Results 
  The age range was from 5 to 12 years with a mean 
age of 7.7 ±2.45 (Figure 1). Majority (54.3 %) were 
males . The weight of the children ranged from 10 to 
40 kg with a mean weight of 237.48 kg. In the 
Azithromycin group majority (69.6 %) became afebrile 
on day 5th .In the Ofloxacin group 48.7% patients 
became afebrile on day 5th.The proportion of patients 
becoming afebrile on day 5th was higher in the 
































Figure 1- Age distribution of study groups 
 
Table 1:  Frequencies of patients becoming afebrile 















     p=0.001 
Discussion 
       The results of present study revealed children 
between age group 7-11 years, mostly infected with 
typhoid fever. This is in contrast to a study which 
showed that children less than 5 years of age are at 
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high risk.18,19 Males were reported more than females 
in our study groups and it may be due to the reason 
that male children have easy access to street foods. 
Similar results were also obtained in Bangladesh in 
which male patients were more in number than the 
female patients infected with typhoid fever.20, 21 In the 
Azithromycin group 69.6 % patients became afebrile 
on day 5. The proportion of patients becoming afebrile 
on day 5 was significantly higher in the Azithromycin 
group as compared to Ofloxacin group; p= 0.01).A 
case series reported from south India showed that 
fluoroquinolone use in fluoroquinolone reduced 
susceptibility strains should be done with great 
caution. 22 Another study compared different 
antimicrobial regimens for the treatment of MDR 
(multidrug resistant) (nalidixic acid resistant) Na (r) 
typhoid fever. Vietnamese children and adults with 
uncomplicated typhoid fever were entered into an 
open randomized controlled trial. Ofloxacin (20mg/kg 
of body weight/day for 7 days), azithromycin 
(10mg/kg/day for the first 3 days) were compared. 
The clinical cure rate was 64% with ofloxacin, 76%  
with ofloxacin-azithromycin, and 82% (51/62) with 
azithromycin . The mean (95% confidence interval, 
fever, clearance time for patients treated with 
azithromycin (5.8 days [5.1 to 6.5 days]) was shorter 
than that for patients treated with ofloxacin-
azithromycin (7.1 days [6.2 to 8.1 days]) and ofloxacin 
(8.2 days [7.2 to 9.2 days]) (p < 0.001).23   According to 
another study conducted in Amirtasir India, the safety 
of ofloxacin and azithromycin is equal in treatment of 
typhoid fever with no major side effects. However 
azithromycin is an effective alternative in conditions 
when ofloxacin is contraindicated. 24 
    In a study it was shown that about 20 % of patients of 
typhoid fever treated with Ofloxacin had positive fecal 
cultures immediately in their post treatment period. 
This transient fecal carriage in post treatment period 
has the potential to allow further transmission of S. 
typhi among the family and close contacts. 23  
    About 80% of the patients among this study group 
who were treated with Azithromycin in a dose of 
10mg/kg/day once daily for 7 days had an average 
fever clearance time on day 5 of treatment and this 
was comparable to results of another study in which 
azithromycin was compared in terms of fever 
clearance time. 23 
 
     Studies have examined a regimen of azithromycin 
at a dose of 20 mg/kg/day (maximum, 1 g/day) in 
children or 1 g/day in adults given for 5 days. Of the 
Egyptian children, 94% (30/32) were cured of the 
disease, with a mean fever clearance time of 4.5 days25. 
Of Vietnamese adults, 96% (42 out of 44) were cured, 
with a mean duration of fever of 5.4 days. 26 The 
slightly lower cure rate in our study as compared to 
these studies may be due to higher doses of 
azithromycin used in these studies. Azithromycin can 
be used  safely for the treatment of typhoid fever in 
children.27 
    The persistence of fever in some patients of our 
study may be due to the continued production of 
pyrogenic cytokines.28 This shows that time taken to 
clear fever may not be an adequate measure of 
antibiotic efficacy, and consequently may not be an 
appropriate end point in typhoid therapy trials. Some 
investigators also did not specify whether clinical 
failures were excluded or included in calculations of 
mean fever clearance time. 
In this study, a 7-day course of azithromycin was more 
effective as an initial oral treatment for uncomplicated 
typhoid fever. Appropriate treatment of typhoid fever 
is a clinical as well as a public health challenge due to 
rising levels of drug resistance and limited evidence 
for use of newer agents like Azithromycin, particularly 
for children.  
Conclusions 
 
1.Azithromycin is a better choice than Ofloxacin in 
terms of shorter time of fever clearance.  
2. Clinical burden of typhoid fever ,along with 
emergence of resistance  to antibiotics which were 
considered appropriate for its treatment , needs 
exploration of  more antibiotic therapies .    
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